Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Imaging, Three-Dimensional | 4 | 2016 | 68 | 1.290 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 96 | 1.200 |
Why?
|
| Mammaplasty | 3 | 2022 | 3 | 1.030 |
Why?
|
| Torso | 3 | 2016 | 4 | 0.870 |
Why?
|
| Breast | 4 | 2022 | 15 | 0.830 |
Why?
|
| Mass Screening | 1 | 2022 | 10 | 0.750 |
Why?
|
| Algorithms | 2 | 2013 | 241 | 0.650 |
Why?
|
| Silicon | 1 | 2020 | 17 | 0.630 |
Why?
|
| Humans | 15 | 2023 | 4936 | 0.510 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 3 | 0.420 |
Why?
|
| Cell Nucleus | 1 | 2013 | 16 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 97 | 0.380 |
Why?
|
| Medical Informatics | 1 | 2010 | 3 | 0.320 |
Why?
|
| Computer Communication Networks | 1 | 2010 | 6 | 0.310 |
Why?
|
| User-Computer Interface | 1 | 2010 | 22 | 0.310 |
Why?
|
| Mastectomy | 2 | 2021 | 5 | 0.310 |
Why?
|
| Software | 1 | 2010 | 57 | 0.310 |
Why?
|
| Telemedicine | 1 | 2010 | 37 | 0.300 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 24 | 0.260 |
Why?
|
| Middle Aged | 5 | 2017 | 967 | 0.220 |
Why?
|
| Female | 7 | 2023 | 2523 | 0.220 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 20 | 0.220 |
Why?
|
| Autophagy | 2 | 2016 | 30 | 0.220 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2023 | 2 | 0.210 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 8 | 0.200 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 14 | 0.200 |
Why?
|
| Adult | 5 | 2017 | 1567 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2022 | 10 | 0.190 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 6 | 0.170 |
Why?
|
| Models, Theoretical | 2 | 2013 | 75 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2021 | 18 | 0.170 |
Why?
|
| Quality of Life | 2 | 2022 | 87 | 0.160 |
Why?
|
| Food Storage | 1 | 2020 | 1 | 0.160 |
Why?
|
| Nanocomposites | 1 | 2020 | 5 | 0.160 |
Why?
|
| Fruit | 1 | 2020 | 12 | 0.160 |
Why?
|
| Boron Compounds | 1 | 2020 | 3 | 0.160 |
Why?
|
| Cell Adhesion | 1 | 2020 | 9 | 0.160 |
Why?
|
| Titanium | 1 | 2020 | 5 | 0.160 |
Why?
|
| Aged | 3 | 2017 | 703 | 0.150 |
Why?
|
| Body Image | 1 | 2017 | 8 | 0.140 |
Why?
|
| Zebrafish | 2 | 2016 | 20 | 0.140 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 24 | 0.140 |
Why?
|
| Cell Line | 2 | 2016 | 84 | 0.130 |
Why?
|
| Cosmetic Techniques | 1 | 2016 | 1 | 0.130 |
Why?
|
| Androgens | 2 | 2016 | 10 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cardiovascular System | 1 | 2016 | 4 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2016 | 13 | 0.130 |
Why?
|
| Environmental Pollutants | 1 | 2016 | 7 | 0.130 |
Why?
|
| Photogrammetry | 1 | 2016 | 1 | 0.130 |
Why?
|
| Normal Distribution | 1 | 2016 | 5 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 14 | 0.130 |
Why?
|
| Disease Progression | 1 | 2016 | 59 | 0.130 |
Why?
|
| Lysosomes | 1 | 2016 | 21 | 0.130 |
Why?
|
| Anthropometry | 1 | 2016 | 11 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2016 | 47 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 55 | 0.120 |
Why?
|
| Young Adult | 2 | 2016 | 787 | 0.120 |
Why?
|
| Posture | 1 | 2015 | 22 | 0.110 |
Why?
|
| Sodium Compounds | 1 | 2014 | 2 | 0.110 |
Why?
|
| Arsenites | 1 | 2014 | 2 | 0.110 |
Why?
|
| Water Pollutants, Chemical | 1 | 2014 | 7 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 17 | 0.100 |
Why?
|
| Aneuploidy | 1 | 2013 | 1 | 0.100 |
Why?
|
| Diploidy | 1 | 2013 | 2 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 318 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 39 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 11 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 10 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 30 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 20 | 0.090 |
Why?
|
| Automation | 1 | 2011 | 13 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2011 | 6 | 0.080 |
Why?
|
| Observer Variation | 1 | 2011 | 16 | 0.080 |
Why?
|
| Surface Properties | 1 | 2011 | 77 | 0.080 |
Why?
|
| Computer Security | 1 | 2010 | 1 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 2010 | 2 | 0.080 |
Why?
|
| Telemetry | 1 | 2010 | 3 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 20 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 161 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2016 | 18 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2016 | 115 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 160 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 4 | 0.050 |
Why?
|
| Telomere | 1 | 2023 | 5 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 2 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 3 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 4 | 0.050 |
Why?
|
| Minority Groups | 1 | 2022 | 35 | 0.050 |
Why?
|
| Egg White | 1 | 2020 | 1 | 0.040 |
Why?
|
| Egg Yolk | 1 | 2020 | 2 | 0.040 |
Why?
|
| Cellulose | 1 | 2020 | 2 | 0.040 |
Why?
|
| Surface Tension | 1 | 2020 | 3 | 0.040 |
Why?
|
| Viscosity | 1 | 2020 | 10 | 0.040 |
Why?
|
| Curcumin | 1 | 2020 | 10 | 0.040 |
Why?
|
| United States | 1 | 2022 | 495 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 1711 | 0.040 |
Why?
|
| Radiotherapy, Conformal | 1 | 2016 | 1 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2016 | 4 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 12 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 12 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 30 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 22 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 20 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 30 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 66 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 60 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 11 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 48 | 0.030 |
Why?
|
| Male | 2 | 2016 | 2491 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 126 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 137 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 177 | 0.030 |
Why?
|
| Texas | 1 | 2016 | 190 | 0.030 |
Why?
|
| Fiducial Markers | 1 | 2015 | 2 | 0.030 |
Why?
|
| Body Height | 1 | 2015 | 4 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 9 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 29 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 68 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 98 | 0.030 |
Why?
|
| Models, Biological | 1 | 2015 | 124 | 0.030 |
Why?
|
| Mice | 1 | 2016 | 685 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2012 | 2 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 23 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 13 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 35 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 54 | 0.020 |
Why?
|